絞り込み

17309

広告

Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.

著者 Stav AL , Aarsland D , Johansen KK , Hessen E , Auning E , Fladby T この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (130view , 1users)

Full Text Sources

Medical

Miscellaneous

Cognitive impairment in early Parkinson's disease (PD) is common and distinct from early Alzheimer's disease. Predictors and mechanisms are only partially known, but α-synuclein, amyloid-β and tau dysmetabolism may be involved. Our aim was to study associations between cerebrospinal fluid biomarkers (CSF) and cognition in non-dementia PD compared to normal controls (NC) and non-PD patients with mild cognitive impairment (MCI non-PD).
PMID: 25971633 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード